Can rheumatologists harness the placebo effect to improve patient care?
Search results for: hip OA
President’s Perspective: Outgoing ACR Leader Audrey B. Uknis, MD, Forecasts Bright Future for Rheumatology
Strides in strategic planning, advocacy, education, leadership development, and research during 2013 have well-positioned the College to advance rheumatology
Dermatology Case Answer E: September
Incorrect E) Mycosis fungoides (MF) MF is a form of CTCL. As mentioned earlier, there is controversy over whether PPD is associated with MF, but many authors believe that PPD merely shares overlapping clinical features with certain rare subtypes of MF. MF can manifest with a wide variety of clinical lesions, including thin scaly patches,…
Dermatology Case Answer D: September
Foot rash on man with hypertension
Dermatology Case Answer C: September
Foot rash on man with hypertension
Dermatology Case Answer A: September
Foot rash on man with hypertension
Dermatology Case Answer B: September
Foot rash on man with hypertension
SGR Fix Finally on the Horizon?
By a 51–0 vote, the House Energy and Commerce Committee in July passed H.R. 2810, legislation that would repeal the Sustainable Growth Rate (SGR) formula. (posted Sept. 9, 2013)
Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology
Visionary rheumatologist credited with developing new spondylarthritis criteria, collaborating on the OASIS study, and promoting the 3E Initiative in rheumatology
Tech Talk: New Technologies Attempt to Find Better Treatments for Rheumatic Diseases
Research in proteomics and genetics sheds new light on treatment strategies, brings potential for breakthroughs
- « Previous Page
- 1
- …
- 263
- 264
- 265
- 266
- 267
- …
- 331
- Next Page »